DSGN compared with FTH: revenue, margins and what each company keeps, and the suppliers and customers both name

DSGNDesign Therapeutics, Inc.

Mkt capRevenueRevenue

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

DSGNDesign Therapeutics, Inc.

FTHFaeth Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DSGN

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±31.2%▼−9.03%×0.29

Q2 FY26±28.1%▲+4.76%×0.17

Apr 29 '26±29.8%▲+23.26%×0.78

Q1 FY26±38.8%▼−3.66%×0.10

FTH2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▲+2.18%—

Q2 FY26—▼−6.73%—

= impliedDSGN realized, solidFTH realized, hatchedOne scale, both sides: full bar = 39%× = |realized| ÷ impliedspan: DSGN 240d · FTH 91dSource: market data

DSGNDesign Therapeutics, Inc.

10.22▲+5.71%· post 10.22

Mkt cap$653.8M

FTHFaeth Therapeutics, Inc.

21.22▲+6.51%· post 25.20

ClosedNov 6 '26

Mkt cap$569.9M

Compare

ClosedNov 6 '26

DSGNDesign Therapeutics, Inc.

FTHFaeth Therapeutics, Inc.

10.22▲+5.71%post 10.22

Price

21.22▲+6.51%post 25.20

$653.8M

Mkt cap

$569.9M

DSGN10.22▲+5.71%vsFTH21.22▲+6.51%ClosedNov 6 '26